Compounds > thiazoles
Page last updated: 2024-08-21

thiazoles and a 85783.0

thiazoles has been researched along with a 85783.0 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albert, DH; Carter, GW; Conway, RG; Davidsen, SK; Holms, JH; Luo, G; Magoc, TJ; Rhein, DA; Summers, JB; Tapang, P1
Albert, DH; Carter, GW; Kleinert, HD; Magoc, TJ; Menacherry, SD; Morgan, DW; Reyes, AE; Summers, JB; Sun, E1
Hood, AF; Morin, SM; Pei, Y; Travers, J1
Dy, LC; Pei, Y; Travers, JB1
Chang, KH; Jeon, EJ; Kim, DH; Lee, SK; Park, YS; Yeo, SW1

Trials

1 trial(s) available for thiazoles and a 85783.0

ArticleYear
Ex vivo inhibition of beta-thromboglobulin release following administration to man of ABT-299, a novel prodrug of a potent platelet activating factor antagonist.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1997, Volume: 46, Issue:7

    Topics: Adolescent; Adult; beta-Thromboglobulin; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Double-Blind Method; Humans; In Vitro Techniques; Indoles; Injections, Intravenous; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prodrugs; Pyridinium Compounds; Thiazoles

1997

Other Studies

4 other study(ies) available for thiazoles and a 85783.0

ArticleYear
ABT-299, a potent antagonist of platelet activating factor.
    Advances in prostaglandin, thromboxane, and leukotriene research, 1995, Volume: 23

    Topics: Animals; Binding, Competitive; Blood Pressure; Edema; Esterases; Humans; Hypotension; Indoles; Kinetics; Lipopolysaccharides; Mice; Molecular Structure; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prodrugs; Pyridinium Compounds; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Shock, Septic; Thiazoles

1995
Antiinflammatory activity of the platelet-activating factor receptor antagonist A-85783.
    Archives of dermatological research, 1998, Volume: 290, Issue:10

    Topics: Animals; Anti-Inflammatory Agents; Ear; Indoles; Inflammation; Male; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Skin; Thiazoles

1998
Augmentation of ultraviolet B radiation-induced tumor necrosis factor production by the epidermal platelet-activating factor receptor.
    The Journal of biological chemistry, 1999, Sep-17, Volume: 274, Issue:38

    Topics: Azepines; Cells, Cultured; Humans; Indoles; Keratinocytes; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; RNA, Messenger; Thiazoles; Triazoles; Tumor Necrosis Factor-alpha; Ultraviolet Rays; Vitamin E

1999
Effects of tumor necrosis factor alpha antagonist, platelet activating factor antagonist, and nitric oxide synthase inhibitor on experimental otitis media with effusion.
    The Annals of otology, rhinology, and laryngology, 2006, Volume: 115, Issue:8

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capillary Permeability; Ear, Middle; Enzyme Inhibitors; Etanercept; Immunoglobulin G; Immunohistochemistry; Indoles; Injections, Intralesional; Injections, Intraperitoneal; Lipopolysaccharides; Multivariate Analysis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Otitis Media with Effusion; Photomicrography; Platelet Activating Factor; Pseudomonas aeruginosa; Rats; Rats, Sprague-Dawley; Receptors, Tumor Necrosis Factor; Thiazoles; Tumor Necrosis Factor-alpha; Tympanic Membrane

2006